Olaparib and temozolomide for relapsed small cell lung cancer
10 Apr 2017
Olaparib and temozolomide for relapsed small cell lung cancer
Treatment choices for HER2 amplified colorectal cancer
Final results of the HERACLES trial in HER2-amplified colorectal cancer
Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours
Neratinib in HER2 or HER3 mutant solid tumours
Understanding response and resistance to cancer therapy: Lessons learned from melanoma
Tumour-treating fields complement chemotherapy in aggressive brain tumours
Cervical cancer reduction with HPV vaccines
75 years of Tata Memorial Centre
Surgery over SBRT for early lung cancer
SBRT or surgery for early lung cancer?
Peer learning in the National Cancer Grid